F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
medical record review, staff and hospice staff interviews, review of medication information from Medscape
and facility medication administration policy, the facility failed to ensure blood pressure medication was
administered in accordance with physician orders. This resulted in a significant medication error when one
resident received an anti-hypertensive blood pressure medication outside of physician prescribed
administration parameters. This affected one (#1) of five sampled residents reviewed for the administration
of medications. The facility census of 85.
Residents Affected - Few
Findings include:
Resident #1 admitted to the facility on [DATE] with the diagnosis including, cardiomyopathy, congestive
heart failure, atrial fibrillation, coronary artery disease, ventricular tachycardia, cardiac pacemaker, seizure
disorder, pulmonary hypertension, pleural effusion, left clavical fracture, and cerebral vascular accident
affecting left non-dominant side with hemiplegia and hemiparesis.
According to the minimum data set assessment dated [DATE] Resident #1 was assessed with intact
cognition and dependent on staff for the completion of activities of daily living. Resident #1 was coded as
receiving antibiotic and antiplatelet medications.
Review of Resident #1 Hospice Patient Medication Profile dated 05/23/24 noted as Resident #1 admission
physician orders revealed an order for Metoprolol Succinate 25 milligram tablet extended release (ER)
ordered on 04/25/24 to be given by mouth as needed (PRN) for hypertension. Give one tablet once daily as
needed for systolic blood pressure (SBP) above 130. Starting on 04/26/2024.
According to Electronic Medical Record noted a physician order dated 05/26/24 for Metoprolol Succinate
ER Oral Tablet Extended Release 24 Hour. Give one tablet by mouth at bedtime for hypertension. No
documentation was provided indicating the physician order was obtained by the hospice physician.
Review of Medication Administration Records (MAR) dated 05/26/24 and 05/27/24 at 9:00 P.M. noted the
residents SBP readings as follows: 05/26/24- 115 and 05/27/24-119. The medication Metoprolol Succinate
25 mg documented to be administered.
On 06/27/24 at 7:38 A.M. telephone interview with hospice Registered Nurse (RN) #201 during review of
Resident #1's medication orders confirmed Metoprolol Succinate 25 milligram tablet extended release
ordered on 04/25/24 to be given by mouth as needed (PRN) for hypertension. Give one tablet once daily as
needed for systolic blood pressure (SBP) above 130. Starting on 04/26/2024. Hospice RN #201 confirmed
the physician order was unchanged from the date of the initial order of 04/25/24 and the medication was
not to be administered unless Resident #1 SBP was above 130. RN #201 also verified the
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
365535
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365535
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/27/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Three Meadows Post Acute
10540 Fremont Pike Rd
Perrysburg, OH 43551
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
hospice physician orders were to be followed by the facility while the resident was receiving Respite
services between 05/26/24 and 05/28/24.
On 06/27/24 at 10:02 A.M. interview with the Director of Nursing (DON) during a review of the medical
record revealed Resident #1 physician orders were to be followed through hospice services. Upon
admission to the facility Resident #1 hospice physician orders included the administration of Metoprolol
Succinate 25 milligram (mg) tablet extended release ordered on 04/25/24 to be given by mouth as needed
(PRN) for hypertension. Administration parameters included give one tablet once daily as needed for
systolic blood pressure (SBP) above 130. Resident #1 SBP ranged between 115 and 119 during his stay at
the facility between 05/26/24 and 05/28/24. The resident received two doses of the Metoprolol Succinate
with one on 05/26/24 at 9:00 P.M. and one on 05/27/24 at 9:00 P.M. The DON confirmed the blood pressure
medication Metoprolol Succinate should have been held and not administered.
Review of medication information from Medscape at
https://reference.medscape.com/drug/lopressor-toprol-xl-metoprolol-342360 revealed Metoprolol is a beta
blocker used to treat hypertension, acute myocardial infarction, congestive heart failure and angina.
Metoprolol works by blocking receptors which helps your heart beat more slowly. These effects can help
your heart work better, lower blood pressure, and may reduce your risk for heart attack and stroke.
Metoprolol should not be used in your blood pressure is too low (hypotension).
According to facility Medication Administration General Guidelines Dated November 2021 revealed
medications are administered in accordance with written orders of the prescriber.
This deficiency represents non-compliance investigated under Complaint Number OH00154517.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365535
If continuation sheet
Page 2 of 2